Health Canada has responded very quickly with regard to reviewing and giving us the authorization to proceed with our clinical trial.
On February 16th, 2021. See this statement in context.
On February 16th, 2021. See this statement in context.
February 16th, 2021 / 12:35 p.m.
Chief Executive Officer, Providence Therapeutics
Health Canada has responded very quickly with regard to reviewing and giving us the authorization to proceed with our clinical trial.
See context to find out what was said next.